Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dipeptidyl Peptidase-4 Modulates Left Ventricular Dysfunction in Chronic Heart Failure via Angiogenesis-Dependent and -Independent Actions
Toshimasa Shigeta, Morihiko Aoyama, Yoshiyuki Bando, et al.
Circulation (2012) Vol. 126, Iss. 15, pp. 1838-1851
Open Access | Times Cited: 159

Showing 1-25 of 159 citing articles:

Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial
Faı̈ez Zannad, Christopher P. Cannon, William C. Cushman, et al.
The Lancet (2015) Vol. 385, Iss. 9982, pp. 2067-2076
Closed Access | Times Cited: 716
Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
Erin E. Mulvihill, Daniel J. Drucker
Endocrine Reviews (2014) Vol. 35, Iss. 6, pp. 992-1019
Open Access | Times Cited: 528
DPP4 in diabetes
Diana Röhrborn
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 387
Cardiovascular Actions of Incretin-Based Therapies
John R. Ussher, Daniel J. Drucker
Circulation Research (2014) Vol. 114, Iss. 11, pp. 1788-1803
Open Access | Times Cited: 318
Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored
John J.V. McMurray, Hertzel C. Gerstein, Rury R. Holman, et al.
The Lancet Diabetes & Endocrinology (2014) Vol. 2, Iss. 10, pp. 843-851
Closed Access | Times Cited: 289
Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control
Giulia Borghetti, Dirk von Lewinski, Deborah Eaton, et al.
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 196
DPP4 in Cardiometabolic Disease
Jixin Zhong, Andrei Maiseyeu, Stephen N. Davis, et al.
Circulation Research (2015) Vol. 116, Iss. 8, pp. 1491-1504
Open Access | Times Cited: 166
Diabetes Mellitus and Ischemic Diseases
Kiave Yune Howangyin, Jean‐Sébastien Silvestre
Arteriosclerosis Thrombosis and Vascular Biology (2014) Vol. 34, Iss. 6, pp. 1126-1135
Open Access | Times Cited: 131
Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system
Annayya R. Aroor, James R. Sowers, Guanghong Jia, et al.
AJP Heart and Circulatory Physiology (2014) Vol. 307, Iss. 4, pp. H477-H492
Open Access | Times Cited: 104
Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells
Bongkun Choi, Sahmin Lee, Sang-Min Kim, et al.
Circulation (2017) Vol. 135, Iss. 20, pp. 1935-1950
Open Access | Times Cited: 95
Diabetic cardiomyopathy
Matthew M.Y. Lee, John J.V. McMurray, Ana Lorenzo-Almorós, et al.
Heart (2018) Vol. 105, Iss. 4, pp. 337-345
Open Access | Times Cited: 95
Are targeted therapies for diabetic cardiomyopathy on the horizon?
Mitchel Tate, David J. Grieve, Rebecca H. Ritchie
Clinical Science (2017) Vol. 131, Iss. 10, pp. 897-915
Open Access | Times Cited: 87
Dipeptidylpeptidase Inhibition Is Associated with Improvement in Blood Pressure and Diastolic Function in Insulin-Resistant Male Zucker Obese Rats
Annayya R. Aroor, James R. Sowers, Shawn B. Bender, et al.
Endocrinology (2013) Vol. 154, Iss. 7, pp. 2501-2513
Open Access | Times Cited: 97
Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes
Akio Monji, Toko Mitsui, Yoshiyuki Bando, et al.
AJP Heart and Circulatory Physiology (2013) Vol. 305, Iss. 3, pp. H295-H304
Closed Access | Times Cited: 95
Left ventricular diastolic dysfunction and myocardial stiffness in diabetic mice is attenuated by inhibition of dipeptidyl peptidase 4
Nazha Hamdani, Anne-Sophie Hervent, Leni Vandekerckhove, et al.
Cardiovascular Research (2014) Vol. 104, Iss. 3, pp. 423-431
Open Access | Times Cited: 74
Dipeptidyl peptidase-4 inhibitor improved exercise capacity and mitochondrial biogenesis in mice with heart failure via activation of glucagon-like peptide-1 receptor signalling
Shingo Takada, Yoshihiro Masaki, Shintaro Kinugawa, et al.
Cardiovascular Research (2016) Vol. 111, Iss. 4, pp. 338-347
Open Access | Times Cited: 71
Recent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical Trials
Jixin Zhong, Quan Gong, Aditya Goud, et al.
Journal of Diabetes Research (2015) Vol. 2015, pp. 1-14
Open Access | Times Cited: 69
Sitagliptin reduces inflammation, fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fraction
Grazia Esposito, Donato Cappetta, Rosa Russo, et al.
British Journal of Pharmacology (2016) Vol. 174, Iss. 22, pp. 4070-4086
Open Access | Times Cited: 69
Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism
Natasha A. Trzaskalski, Evgenia Fadzeyeva, Erin E. Mulvihill
Clinical Medicine Insights Endocrinology and Diabetes (2020) Vol. 13, pp. 117955142091297-117955142091297
Open Access | Times Cited: 68
Increased dipeptidyl peptidase-4 accelerates diet-related vascular aging and atherosclerosis in ApoE-deficient mice under chronic stress
Yanna Lei, Guang Yang, Lina Hu, et al.
International Journal of Cardiology (2017) Vol. 243, pp. 413-420
Closed Access | Times Cited: 63
Diabetes-Related Heart Failure
Yoshiyuki Bando, Toyoaki Murohara
Circulation Journal (2014) Vol. 78, Iss. 3, pp. 576-583
Open Access | Times Cited: 66
Chronic Psychological Stress Accelerates Vascular Senescence and Impairs Ischemia‐Induced Neovascularization: The Role of Dipeptidyl Peptidase‐4/Glucagon‐Like Peptide‐1‐Adiponectin Axis
Limei Piao, Guangxian Zhao, Enbo Zhu, et al.
Journal of the American Heart Association (2017) Vol. 6, Iss. 10
Open Access | Times Cited: 61
Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats
Toru Miyoshi, Kazufumi Nakamura, Masashi Yoshida, et al.
Cardiovascular Diabetology (2014) Vol. 13, Iss. 1, pp. 43-43
Open Access | Times Cited: 60
Subendocardial Systolic Dysfunction in Asymptomatic Normotensive Diabetic Patients
Mami Enomoto, Tomoko Ishizu, Yoshihiro Seo, et al.
Circulation Journal (2015) Vol. 79, Iss. 8, pp. 1749-1755
Open Access | Times Cited: 56
Vildagliptin Stimulates Endothelial Cell Network Formation and Ischemia-induced Revascularization via an Endothelial Nitric-oxide Synthase-dependent Mechanism
Masakazu Ishii, Rei Shibata, Kazuhisa Kondo, et al.
Journal of Biological Chemistry (2014) Vol. 289, Iss. 39, pp. 27235-27245
Open Access | Times Cited: 56
Page 1 - Next Page

Scroll to top